Search for: "United States v. Matthews" Results 81 - 100 of 1,741
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Apr 2023, 5:00 am by Overhauser Law Offices, LLC
In 2010, Judge Brookman received the Director’s Award from United States Attorney General Eric Holder, in Washington, DC, for superior performance as an Assistant United States Attorney, for his work on the United States v. [read post]
11 Apr 2023, 3:48 am by Seán Binder
Matthew Luxmoore reports for the Wall Street Journal. [read post]
At the close of business on Good Friday, federal judge Matthew Kacsmaryk released a ruling in Alliance for Hippocratic Medicine vs. [read post]
6 Apr 2023, 10:51 am by bndmorris
SUPREME COURT OF THE UNITED STATES 59. [read post]
4 Apr 2023, 10:17 pm by Jonathan Zasloff
That standard was most recent reaffirmed by the United States Supreme Court in MedImmune v Genentech, which stated: [Our cases] do not draw the brightest of lines between those declaratory-judgment actions that satisfy the case-or-controversy requirement and those that do not. [read post]
23 Mar 2023, 1:27 pm by Ronald Mann
Matthew Guarnieri, assistant to the solicitor general, argues for the United States. [read post]
22 Mar 2023, 7:03 am by Dennis Crouch
  As Abitron wrote in it its brief: these “were sales in foreign countries, by foreign sellers, to foreign customers, for use in foreign countries, that never reached the United States or confused U.S. consumers. [read post]
22 Mar 2023, 5:58 am by madeo-design
Bush appointed her to the United States District Court for the Southern District of New York. [read post]
19 Mar 2023, 2:56 pm by Howard Friedman
As previously reported, the case challenges the FDA's long-standing approval for use in the United States of the chemical abortion drug mifepristone. [read post]
18 Mar 2023, 8:08 am by Guest Author
In a new article, “The Law of AI for Good,” I seek to apply insights from The Equality Machine by critically examining the current legislative and regulatory reforms being introduced in the United States and Europe and argue that these are limited in their reach and too narrow in their vision on what a tech regulatory scheme can and should look like. [read post]